3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
3
Lymphoma
3
Lung Neoplasms
2
Hematologic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 2a
1
Melanoma
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
X-Rays
6
Specimen Handling
6
Magnetic Resonance Spectroscopy
6
Biopsy
6
Temozolomide
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Cyclophosphamide
5
Irinotecan
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
ivosidenib
2
fludarabine phosphate
2
erdafitinib
2
ensartinib
2
dinutuximab
2
Topotecan
2
Etoposide
2
Doxorubicin
2
Carboplatin
2
trametinib
1
tazemetostat
1
talazoparib
1
saponin QA-21V1
1
palbociclib
1
olaparib
1
larotrectinib
1
irinotecan sucrosofate
1
fludarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroblastoma
×
Crizotinib
×
30 days
×
Clear all
No trials found.